search
Back to results

Treatment and Mapping of Impostor Phenomenon

Primary Purpose

Dermatoses, Vestibulodynia, Hyperhidrosis

Status
Not yet recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Impostor tasks
Sponsored by
Umeå University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dermatoses

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Persons attending the Dept of Dermatology and Venereology due to dermatological diseases or pain - Exclusion Criteria: Age under 18, not able to read/speak Swedish -

Sites / Locations

  • Dept of Public Health and Clinical Medicine, Umeå University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment for five weeks

Arm Description

The patients will get questionnaires before and 12 weeks and 24 weeks after intervention. The intervention will last for 5 weeks.

Outcomes

Primary Outcome Measures

Signs of impostor
Questionnaire regarding impostor
Signs of disease/pain
Questionnaire regarding symptoms

Secondary Outcome Measures

Full Information

First Posted
March 9, 2023
Last Updated
March 27, 2023
Sponsor
Umeå University
search

1. Study Identification

Unique Protocol Identification Number
NCT05805696
Brief Title
Treatment and Mapping of Impostor Phenomenon
Official Title
Treatment and Mapping of Self-compassion, Perfectionism, Stress, Anxiety and Impostor Phenomenon in Patients With Different Dermatological Diseases and Pain
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 1, 2023 (Anticipated)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Umeå University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to evaluate persons/patients with different skin diseases or pain to evaluate whether unhealthy perfectionism, stress, anxiety, impostor phenomenon (inability to realistically assess your competence and skills) and lack of self-compassion (a positive attitude towards ourselves), have impact on symptoms, handling, and treatment regarding some dermatological diseases/pain.
Detailed Description
The investigators have noticed that these conditions are common among patients attending the clinic. The investigators therefore want to do mapping of the occurrence and make an intervention to be able to change and evaluate handling of these patients. The hypothesis is that there is a connection between these conditions and that they are all part of the patients´ disease. The study will be done by using validated questionnaires which are answered anonymously using a code, that is known only by the participant, and with exercises/interventions for five or ten weeks. The questionnaires and interventions are formerly used in several international studies and by the investigators in populations of healthy persons with different professions. Examples of diseases: Localised provoked vulvodynia (former vulvar vestibulitis) is a state of pain that mainly affects young women. The symptoms are localized to the vulvar vestibulum and provoked by touch and experienced by the patient as pain or burning. The aetiology is not clearly known but probably due to both physical and psychological factors. Treatment is due to several strategies like treating the pain, rehabilitation of the perineum, and psychosocial support. Persons with this type of pain will also answer a short questionnaire regarding their symptoms. Hyperhidrosis is excessive sweating without known cause. Hyperhidrosis may be primary focal or multifocal with debut in childhood. Secondary hyperhidrosis is often due to another disease. Hyperhidrosis often means big stress on mental health but may also affect physical functions. Persons with hyperhidrosis estimate their quality of life equal with those affected by severe acne or psoriasis. The investigators´ ongoing research with mapping of these different traits of character shows that the occurrence is increasing, but no treatment has so far been available in Sweden. The investigators therefore want to evaluate whether treatment by intervention with one or two exercises each week may diminish the occurrence of impostor phenomenon and to be able to influence the disease. The questionnaires that will be used are "Self-Compassion scale short version" (SCS-SF), "Clance Impostor Phenomenon scale" (CIPS), "Perceived Stress scale 4" (PSS-4), "Generalized Anxiety Disorder-2" (GAD-2), and "Clinical Perfectionism Questionnaire short form" (CPQ-SF). These questionnaires are validated by other investigators and used in several international research studies. The questionnaires have already been translated from English to Swedish, except CIPS that has been translated and back-translated. There will also be questions on gender, age, and term. The software for statistical analyses is Statistical Package for the Social Sciences (SPSS) version 27 from International Business Machines Corporation (IBM). Before starting treatment, the participants will get a web-based survey including twenty questions about impostor phenomenon (CIPS), six questions about stress and anxiety (PSS-4 and GAD-2), twelve questions about self-compassion (SCS-SF) and six questions about perfectionism (CPQ-SF). The questionnaires are repeated week twelve and 24 after intervention. After inclusion and answering the first questionnaire the persons are asked to participate in a series of one or two interventions, 30 minutes each, every week for ten or five weeks respectively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dermatoses, Vestibulodynia, Hyperhidrosis, Pain Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All patients will get the same questionnaires and the same intervention
Masking
None (Open Label)
Masking Description
The participants will get a code to use for all questionnaires. The questionnaires and the intervention messages will be handled by a person that will not be involved in the answers. The questionnaires will be answered on-line with a code and handled by a person not former involved and thus completely unaware of which patients are attending.
Allocation
N/A
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment for five weeks
Arm Type
Experimental
Arm Description
The patients will get questionnaires before and 12 weeks and 24 weeks after intervention. The intervention will last for 5 weeks.
Intervention Type
Behavioral
Intervention Name(s)
Impostor tasks
Intervention Description
Tasks to do every week
Primary Outcome Measure Information:
Title
Signs of impostor
Description
Questionnaire regarding impostor
Time Frame
At the beginning, after 12 and 24 weeks
Title
Signs of disease/pain
Description
Questionnaire regarding symptoms
Time Frame
At the beginning, after 12 and 24 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Persons attending the Dept of Dermatology and Venereology due to dermatological diseases or pain - Exclusion Criteria: Age under 18, not able to read/speak Swedish -
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elisabet Nylander, MD, PhD
Phone
+46907859191
Email
elisabet.nylander@umu.se
First Name & Middle Initial & Last Name or Official Title & Degree
Jens Boman, MD, PhD
Phone
+46907851111
Email
jens.boman@umu.se
Facility Information:
Facility Name
Dept of Public Health and Clinical Medicine, Umeå University
City
Umeå
ZIP/Postal Code
90186
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Treatment and Mapping of Impostor Phenomenon

We'll reach out to this number within 24 hrs